Supplementary Table 12 from EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner
Year: 2024
Type: supplementary-materials
Abstract: Hallmark pathways negatively enriched in ID8-R cells treated with combinatory EZM8266/Olaparib compared to DMSO control.
Authors: Lily L. Nguyen, Zachary L. Watson, Raquel Ortega, Elizabeth R. Woodruff, Kimberly R. Jordan, Ritsuko Iwanaga, Tomomi M. Yamamoto, Courtney A. Bailey, Francis To, Shujian Lin, Fabian R. Villagomez, Abigail D. Jeong, Saketh R. Guntupalli, Kian Behbakht, Veronica Gibaja, Nausica Arnoult, Edward B. Chuong, Benjamin G. Bitler
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4404975229